Category Archives: entrepreneurship

RWJF Report: Personal Data for the Public Good

Solid report on personal health data. Interesting observation re. (lack of) alignment between research and business objectives… i.e. public vs private goods?

http://www.rwjf.org/en/research-publications/find-rwjf-research/2014/03/personal-data-for-the-public-good.html

Report: http://www.rwjf.org/content/dam/farm/reports/reports/2014/rwjf411080

PDF:

1. Executive Summary
Individuals are tracking a variety of health-related data via a growing number of wearable devices and smartphone apps. More and more data relevant to health are also being captured passively as people communicate with one another on social networks, shop, work, or do any number of activities that leave “digital footprints.”
Almost all of these forms of “personal health data” (PHD) are outside of the mainstream of traditional health care, public health or health research. Medical, behavioral, social and public health research still largely rely on traditional sources of health data such as those collected in clinical trials, sifting through electronic medical records, or conducting periodic surveys.
Self-tracking data can provide better measures of everyday behavior and lifestyle and can fill in gaps in more traditional clinical data collection, giving us a more complete picture of health. With support from the Robert Wood Johnson Foundation, the Health Data Exploration (HDE) project conducted a study to better understand the barriers to using personal health data in research from the individuals who track the data about their own personal health, the companies that market self-tracking devices, apps or services and aggregate and manage that data, and the researchers who might use the data as part of their research.
Perspectives
Through a series of interviews and surveys, we discovered strong interest in contributing and using PHD for research. It should be noted that, because our goal was to access individuals and researchers who are already generating or using digital self-tracking data, there was some bias in our survey findings—participants tended to have more education and higher household incomes than the general population. Our survey also drew slightly more white and Asian participants and more female participants than in the general population.
Individuals were very willing to share their self-tracking data for research, in particular if they knew the data would advance knowledge in the fields related to PHD such as public health, health care, computer science and social and behavioral science. Most expressed an explicit desire to have their information shared anonymously and we discovered a wide range of thoughts and concerns regarding thoughts over privacy.

Equally, researchers were generally enthusiastic about the potential for using self-tracking data in their research. Researchers see value in these kinds of data and think these data can answer important research questions. Many consider it to be of equal quality and importance to data from existing high quality clinical or public health data sources.
Companies operating in this space noted that advancing research was a worthy goal but not their primary business concern. Many companies expressed interest in research conducted outside of their company that would validate the utility of their device or application but noted the critical importance of maintaining their customer relationships. A number were open to data sharing with academics but noted the slow pace and administrative burden of working with universities as a challenge.
In addition to this considerable enthusiasm, it seems a new PHD research ecosystem may well be emerging. Forty-six percent of the researchers who participated in the study have already used self-tracking data in their research, and 23 percent of the researchers have already collaborated with application, device, or social media companies.
The Personal Health Data Research Ecosystem
A great deal of experimentation with PHD is taking place. Some individuals are experimenting with personal data stores or sharing their data directly with researchers in a small set of clinical experiments. Some researchers have secured one-off access to unique data sets for analysis. A small number of companies, primarily those with more of a health research focus, are working with others to develop data commons to regularize data sharing with the public and researchers.
SmallStepsLab serves as an intermediary between Fitbit, a data rich company, and academic researchers via a “preferred status” API held by the company. Researchers pay SmallStepsLab for this access as well as other enhancements that they might want.
These promising early examples foreshadow a much larger set of activities with the potential to transform how research is conducted in medicine, public health and the social and behavioral sciences.

Opportunities and Obstacles
There is still work to be done to enhance the potential to generate knowledge out of personal health data:

Privacy and Data Ownership: Among individuals surveyed, the dominant condition (57%) for making their PHD available for research was an assurance of privacy for their data, and over 90% of respondents said that it was important that the data be anonymous. Further, while some didn’t care who owned the data they generate, a clear majority wanted to own or at least share ownership of the data with the company that collected it.

Informed Consent: Researchers are concerned about the privacy of PHD as well as respecting the rights of those who provide it. For most of our researchers, this came down to a straightforward question of whether there is informed consent. Our research found that current methods of informed consent are challenged by the ways PHD are being used and reused in research. A variety of new approaches to informed consent are being evaluated and this area is ripe for guidance to assure optimal outcomes for all stakeholders.

Data Sharing and Access: Among individuals, there is growing interest in, as well as willingness and opportunity to, share personal health data with others. People now share these data with others with similar medical conditions in online groups like PatientsLikeMe or Crohnology, with the intention to learn as much as possible about mutual health concerns. Looking across our data, we find that individuals’ willingness to share is dependent on what data is shared, how the data will be used, who will have access to the data and when, what regulations and legal protections are in place, and the level of compensation or benefit (both personal and public).

Data Quality: Researchers highlighted concerns about the validity of PHD and lack of standardization of devices. While some of this may be addressed as the consumer health device, apps and services market matures, reaching the optimal outcome for researchers might benefit from strategic engagement of important stakeholder groups.

We are reaching a tipping point. More and more people are tracking their health, and there is a growing number of tracking apps and devices on the market with many more in development. There is overwhelming enthusiasm from individuals and researchers to use this data to better understand health. To maximize personal data for the public good, we must develop creative solutions that allow individual rights to be respected while providing access to high-quality and relevant PHD for research, that balance open science with intellectual property, and that enable productive and mutually beneficial collaborations between the private sector and the academic research community.

Healthy Ageing Japan-style

 

http://www.abc.net.au/radionational/programs/saturdayextra/japan27s-aging-population/5397864

Japan’s ageing population

Saturday 26 April 2014 8:30AM

A quarter of Japanese people are now aged over 65, with predictions that nearly half the population will reach that age by the end of the century.

In Japan people don’t just live longer, they work longer, stay healthier and approach old age in some interesting and innovative ways.

One policy initiative is old age day care which is well used and well organised in Japan.

Guests

Professor John Creighton Campbell
Visiting scholar, Institute of Gerontology at Tokyo University

Credits

Presenter
Dr Norman Swan
Producer
Kate Pearcy

The Story of Digital Health

http://www.nuviun.com/nuviun-digital-health

good infographics…

 

Digital Health Venn Nuviun

 

http://storyofdigitalhealth.com/infographic/

 

Digital_Health_Infographic

Infographic

I created this conceptual infographic illustrating the increasing health benefits achievable with digital health with the great team at Misfit Wearables. You can download a high-resolution version by clicking on the image.

Digital_Health_Infographic

References:
Number of people sequenced
“250,000 human genomes will be fully sequenced by the end of 2012, 1 million by 2013, and 5 million by 2014″ -Topol, Eric (2011-12-02). The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care (p. 102). Perseus Books Group. Kindle Edition.

Also, compliments of Story of Digital Health strategic partner nuviun, there’s this interactive diagram of the digital health landscape…

nuviun-digital-health-landscape

 

an idea of earth shattering significance

ok.

been looking for alignment between a significant industry sector and human health. it’s a surprisingly difficult alignment to find… go figure?

but I had lunch with joran laird from nab health today, and something amazing dawned on me, on the back of the AIA Vitality launch.

Life (not health) insurance is the vehicle. The longer you pay premiums, the more money they make.

AMAZING… AN ALIGNMENT!!!

This puts the pressure on prevention advocates to put their money where their mouth is.

If they can extend healthy life by a second, how many billions of dollars does that make for life insurers?

imagine, a health intervention that doesn’t actually involve the blundering health system!!?? PERFECT!!!

And Australia’s the perfect test bed given the opt out status of life insurance and superannuation.

Joran wants to introduce me to the MLC guys.

What could possibly go wrong??????

Dodgy wearables…

Dodgy wearables indiegogo pitch.

Airo gets a mention.

OK, I get it.

http://pando.com/2014/03/20/on-indiegogo-a-miracle-health-device-raises-730k-and-a-whole-load-of-red-flags/

On Indiegogo, a miracle health device crowdfunds $730k. One problem: it might be total bullshit

319462_10150807895075313_1360808361_nBY 
ON MARCH 20, 2014

healbe
It’s the stuff that crowdfunding dreams are made of.

An Indiegogo campaign for a gorgeous piece of wearable tech, shown off in a slick video with some great visuals. Speaking with a thick Russian accent, Healbe CEO Artem Shipitsyn describes what his company calls the ‘The Original 100% Automatic Body Manager.’ It’s called the ‘GoBe’ and it does everything a Fitbit can but so, so much more. Using Healbe’s “Flow” technology – pressure and impedance sensors mixed with an accelerometer – the device is capable of reading glucose levels through your skin to give an accurate calorie count of everything you’ve eaten, against all the energy we’ve burnt. Despite Shipitsyn’s accent, the device’s Indiegogo page says that the company is based in San Francisco.

“Tell it nothing. Know everything. Go be you,” the video signs off. The GoBe will be delivered by June of this year, to anyone who stumps up just $199.

This, ladies and gentlemen, is a market changer. Step right up!

And people have certainly stepped up. As of midday today, Shipitsyn’s campaign has raised $730,294 in two weeks, from 3253 backers — more than seven times its initial funding goal. Thirty-three backers have paid $1175 for a “Club Pack” including ten GoBe-s.

No shame in admitting it: I was impressed. If GoBe did what it claimed, this was the end of the Fitbit, the Up and just about every other weight loss technology.

And so, keen to be the first reporter to cover this marvelous piece of technology, I started asking questions. What I discovered was something far from the slick, bay area startup Healbe purported to be. Rather, I found a publicity shy company, operated remotely from Russia, promoting a device unsupported by any medical or scientific evidence whatsoever. One that thousands of backers have supported to the tune of almost three quarters of a million dollars, and one that Indiegogo says raises no red flags. In the exact words from an Indiegogo spokesperson: ”We have no reason to believe that this company’s Indiegogo campaign is at all fraudulent.”

[UPDATE: The day after publication, a different spokesperson for Indiegogo took issue with the idea that no red flags were ever raised by the campaign, finally confirming to us that the campaign was indeed investigated– and cleared– by Indiegogo’s usual anti-fraud methods. She declined to explain why the basic mistruths and inconsistencies we found in our reporting– which haven’t been denied by Healbe– didn’t concern Indiegogo. She also declined to explain what types of discoveries would lead Indiegogo to conclude an offering was fraudulent.]

My initial doubts were raised last week when I contacted the company’s information line and received no response. This is odd. Normally when I contact the folks behind crowdfunding campaigns, the response is prompt, and enthusiastic. The more publicity, the more money, after all.

I try again this past Monday. Finally, Meghan Donovan, from MicroArts Creative Agency in Greenland, New Hampshire replies, asking if we can talk the next day. There’s just one problem, she explains when we speak: everyone at Healbe was travelling through the end of the week. She promises to get back to me within a couple of days.

A Google search shows that the GoBe has been the subject of about two dozen press articles, but all of them either quote from the press release or the Indiegogo campaign itself. No major tech website has covered the device, and no scientists seem to be as excited as I am about its apparent medical breakthrough. Healbe might be the most press-shy successful startup on earth.

Artem Shipitsyn (also spelt as Shipitsin) and five of his six colleagues listed on the Indiegogo page – George Mikaberydze, Stanislav Povolotskiy, Michael Rubin, Eugene Sokolov, Pavel Mussel – are traceable online only in relation to this one Indiegogo campaign. Shipitsyn lists himself on the page as “a major developer of market solutions and new products for global brands such as Rostelcorn, Sberbank, L’Oreal, Valio, Reebok, Hearst Shkulev, Discovery Channel and more.” And yet on hisLinkedIn profile he lists none of that, describing himself instead as the owner, since 2004, of Iridium, a marketing company in Russia with little discernible online footprint. And now the CEO of Healbe.

Healbe’s website lists no contact details except for the email address that connected me to Donovan’s PR agency in New Hampshire. An address listed for Healbe Incorporated on an old version of its website leads to a law firm, White Summers, in Redwood City. A receptionist for White Summers confirms that Healbe is a client. The company itself is registered in Delaware. This is apparently the extent of its American infrastructure.

Meanwhile, some of GoBe’s backers are getting cold feet: requests for refunds are starting to trickle on to Healbe’s Indiegogo page, dissent is growing on the company’s Facebook and a few Redditers are getting twitchy.

Michelle MacDonald, a clinical dietician at the National Jewish Health hospital in Denver, tells me that her eyebrows were raised almost immediately when she read Healbe’s claims that, through an “algorithm,” it can work out from glucose levels in our cells what our caloric intake was. “Of course they’re claiming an algorithm, because it’s a fun word,” McDonald laughs.

The problem is, MacDonald explains, the three main nutrients that determine caloric intake are carbohydrates, protein and fats. Glucose provides only a small part of the picture. A company that invented a non-invasive way to measure glucose would be a huge hit with the treatment of diabetes. Currently, diabetes sufferers have to prick their skin and make themselves bleed. The technology is probably coming soon, MacDonald says, but when it does it will be the size of a shoebox. It will also likely involve some form of infrared light shone through the skin that will measure the fluid in interstitial cells to approximate the blood glucose level in a simple milligrams per deciliter figure. It will come from a big lab, will be huge news and make a lot of money.

“If you actually had this technology, Indiegogo would be the last channel you’d go through,” MacDonald says.

Let’s imagine that Healbe really has perfected this technology, though. Even so, MacDonald says, nothing described in the video could do what it claims to. The impedance monitor could look at hydration, the pressure monitor could examine pulse and the accelerometer could tell us about action. But none of those three things could tell you anything about glucose levels. A graphic of Healbe’s accompanying smartphone app even shows it measuring fat and carbohydrates, which is doubly ridiculous.

MacDonald takes particular umbrage at Healbe listing its chief scientist Eugene Sokolov as having a background as a rocket scientist. “I wish I was a standup comedian. I could really run with that,” she laughs. Maybe they’ve left out the key part from the video, she hedges. “But when you fail to explain it, that’s always a red flag.”

In fact there are multiple red flags.

I call Meghan Donovan back. She assures me that the GoBe is a real, working device. Her company was employed by Healbe in Fall 2013 and Shipitsyn came into the MicroArts office to film the Indiegogo video in January. He bought two models in for the video, but Donovan admits that she never saw the device in action. Shipitsyn told her that they were doing their own internal tests. But, she tells me, Healbe displayed its product at CES. That’s something.

On closer inspection, Healbe’s Indiegogo page talks about having “unveiled” the GoBe at CES. Except when I look, there’s no reference to Healbe in the CES directory of exhibiting companies in 2014.

I talk to Healbe’s industrial designer Jozeph Forakis, who has done work for Motorola and Swatch in the past. Over Skype from Italy, Forakis confirms that he has worked with Shipitsyn and Healbe for a year on several different prototypes, “the most recent of which were shown in January in CES.”

Why, then, can’t I find any reference to Healbe in the CES directory? Well, Healbe wasn’t technically at CES Forakis admits. But Shipitsyn was in Las Vegas at the time, taking meetings in his hotel room.

Forakis and Donovan are the only two people I can find who claim to have seen a GoBe in real life. Neither are willing to vouch for the science behind it.

At least Indiegogo believes in Shipitsyn. The Healbe campaign raises no red flags, a company spokesperson tells me. Indiegogo, she says, has a vested interest in security. It prides itself on its “equal opportunity, open platform… literally anyone from anywhere in the world can raise money here.”

In October last year, a Canadian company called Airo Health promised a wearable that could do the same thing as Healbe, with a slightly different technique – looking at nutrient levels in our blood by shining a light through it. The company took pre-orders through its website, but a month later refunded all of its customers. “Through conversations with others in the industry, we have come to realize that it requires further testing,” the company said in a release.

Indiegogo protects itself against fraud with an algorithm — that word again — that detects troublesome accounts, alongside human vetting and the group mentality of crowdfunding picking  out bad eggs.

Fraud is a slippery term, though. It doesn’t account for more subtle manipulations. Healbe’s Gobe activity tracker looks enough like a Fitbit that the average shopper can grasp what it is, and what it might be able to do. The automatic calorie reader claim is an advancement that we can all appreciate the significance of, but few of us can pick apart the science behind. Indiegogo can protect against an outright fraudster, but a snake oil salesman with an unproven product is a different matter. Since the beginning of recorded history, opportunists have been using impressive pitches to sell miracle health potions and devices — really the only thing that’s changed is the technology (although it used to be that if you were conned by a snake oil salesman, at least you’d end up with a pretty glass bottle. Indiegogo can’t even promise that.)

Indiegogo wants to keep these concerns inside the domain of the campaigner-funder relationship. Despite $730,000 in pledges, Indiegogo’s position is that as long as there’s a real company claiming to make something that doesn’t violate its terms of service, it has no moral or legal obligation to ensure that the GoBe is legit. All backers can do is wait until June to see if their miracle band shows up and does what it says in the video.

I was finally able to reach Shipitsyn and Healbe’s managing director George Mikaberydze this morning in Moscow, Russia, via Skype, two hours before my deadline for this piece. Their schedules had apparently become more flexible since I started asking questions.

Shipitsyn holds the device close to the camera — it seems to be the same as in the video — while Mikaberydze points to a fuzzy line on an app that, he says, breaks down his energy consumption over the last 20 minutes since he ate a Snickers bar. They were at CES, they say, as the guest of Levin Consulting, with their own meeting room. They hold up an attendee badge showing, at least, that they visited the conference.

So what about the science? Shipitsyn says that the impedance monitor in the Gobe can measure glucose by monitoring the water moving in and out of cells. Insulin opens up the cells when you eat sugar, he says. The company will publish their own clinical tests soon and are discussing with a third party clinic in America, Shipitsyn insists. They’ve slipped off the medical radar because the accuracy rates range between 80 and 90 percent. The head of Samsung Russia is apparently a huge fan.

It’s a breezy, confident pitch. Shipitsyn and Mikaberydze have a ready response to all of my concerns — the subtext being that I really ought to trust them.

But here’s the rub: I don’t. Or at least not enough to part with $199 for a device for which they haven’t yet released any clinical test results (despite their insistence that these apparently do exist) and which, right now, only exists as a demo on a screen.

I’ve jostled myself right up to the soapbox, pushed my face as close to the screen as it’s possible to get, and I still have absolutely no hard evidence that this device is any more than a smart mock up. Shipitsyn says its a miracle machine, at least one expert says it can’t possibly exist.

What I know for a fact is this: in about three weeks, Healbe will be close to three quarters of a million dollars richer, at least. Indiegogo says they have no reason to withhold the money raised, or to doubt that it will be used to deliver GoBes to three-and-a-bit thousand backers who have, presumably, weighed up the risks for themselves and decided to put their faith in Shipitsyn and his partners. Shipitsyn himself says there’s nothing to worry about, but it won’t be until at least June — plenty of time for the money to have moved from a Delaware corporation to a bank account in Moscow — before we know the truth.

Pando will keep pushing HealBe to publish their trial results and I’ll embed them in this post if and when they do. In the meantime, anyone who is inclined to bet $199 or more on a miracle weight loss device might recall the old maxim: if something seems too good to be true, it probably is.

Shipitsyn has a hell of a pitch, but my $199 is staying in my pocket.

See here for the latest updates on this story.

319462_10150807895075313_1360808361_n

James Robinson is a staff writer for PandoDaily covering hardware, advertising technology and the Internet of Things… among many other general goings on. Follow him on Twitter: @jalrobinson

Greg Ellis (ex-REA CEO) leaving for Germany

http://www.abc.net.au/radionational/programs/saturdayextra/growing-aust-business/5364200

Growing Australian business

Saturday 5 April 2014 8:05AM

One of Australia’s most creative businessmen has joined a small but definitely growing critique of our national business culture.

Greg Ellis, the outgoing Chief Executive of the REA Group – the online real estate classified business, that’s rapidly increased in value under his leadership – strongly believes that Australian business needs a lot more fresh ideas.

Ornish on Digital Health

The limitations of high-tech medicine are becoming clearer—e.g., angioplasty, stents, and bypass surgery don’t prolong life or prevent heart attacks in stable patient; only one out of 49 men treated for prostate cancer benefit from the treatment, and the other 48 often become impotent, incontinent or both; and drug treatments of type 2 diabetes don’t work nearly as well as lifestyle changes in preventing the horrible complications.

http://www.forbes.com/sites/johnnosta/2014/03/17/the-stat-ten-dean-ornish-on-digital-health-wisdom-and-the-value-of-meaningful-connections/

3/17/2014 @ 11:09AM |1,095 views

The STAT Ten: Dean Ornish On Digital Health, Wisdom And The Value Of Meaningful Connections

STAT Ten is intended to give a voice to those in digital health. From those resonant voices in the headlines to quiet innovators and thinkers behind the scenes, it’s my intent to feature those individuals who are driving innovation–in both thought and deed. And while it’s not an exhaustive interview, STAT Ten asks 10 quick questions to give this individual a chance to be heard.  

Dean Ornish, MD is a fascinating and important leader in healthcare.  His vision has dared to question convention and look at health and wellness from a comprehensive and unique perspective.  He is a Clinical Professor of Medicine, UCSF Founder & President, nonprofit Preventive Medicine Research Institute.

Dr. Ornish’s pioneering research was the first to prove that lifestyle changes may stop or even reverse the progression of heart disease and early-stage prostate cancer and even change gene expression, “turning on” disease-preventing genes and “turning off” genes that promote cancer, heart disease and premature aging. Recently, Medicare agreed to provide coverage for his program, the first time that Medicare has covered an integrative medicine program. He is the author of six bestselling books and was recently appointed by President Obama to the White House Advisory Group on Prevention, Health Promotion, and Integrative and Public Health. He is a member of the boards of directors of the San Francisco Food Bank and the J. Craig Venter Institute. The Ornish diet was rated #1 for heart health by U.S. News & World Report in 2011 and 2012. He was selected as one of the “TIME 100” in integrative medicine, honored as “one of the 125 most extraordinary University of Texas alumni in the past 125 years,” recognized by LIFE magazine as “one of the 50 most influential members of his generation” and by Forbes magazine as “one of the 7 most powerful teachers in the world.”

The lexicon of his career is filled with words that include innovator, teacher and game-changer.  And with this impressive career and his well-established ability to look at health and medicine in a new light, I thought i would be fun–and informative–to ask Dr. Ornish some questions about digital health.

Dean Ornish, MD

Dean Ornish, MD

 1. Digital health—many definitions and misconceptions.  How would describe this health movement in a sentence or two?

“Digital health” usually refers to the idea that having more quantitative information about your health from various devices will improve your health by changing your behaviors.  Information is important but it’s not usually sufficient to motivate most people to make meaningful and lasting changes in healthful behaviors.  If it were, no one would smoke cigarettes.

2. You’ve spoken of building deep and authentic connection among  patients as key element of your wellness programs.  Can digital health foster that connection or drive more “techno-disconnection”?

Both.  What matters most is the quality and meaning of the interaction, not whether it’s digital or analog (in person).  Study after study have shown that people who are lonely, depressed, and isolated are three to ten times more likely to get sick and die prematurely compared to those who have a strong sense of love and community.  Intimacy is healing.  In our support groups, we create a safe environment in which people can let down their emotional defenses and communicate openly and authentically about what’s really going on in their lives without fear they’ll be rejected, abandoned, or betrayed.  The quality and meaning of this sense of community is often life-transforming.  It can be done digitally, but it’s more effective in person.  A digital hug is not quite as fulfilling, but it’s much better than being alone and feeling lonely.

3. How can we connect clinical validation to the current pop culture trends of “fitness gadgets”?

Awareness is the first step in healing.  In that context, information can raise awareness, but it’s only the first step.

 4. Can digital health help link mind and body wellness?

Yes.  Nicholas Christakis’ research found that if your friends are obese, your risk of obesity if 45% higher.  If your friends’ friends are obese, your risk of obesity if 25% higher.  If your friends’ friends’ friends are obese, your risk is 10% higher—even if you’ve never met them.  That’s how interconnected we are.  Their study also showed that social distance is more important than geographic distance.  Long distance is the next best thing to being there (and in some families, even better…).

5. Are there any particular area of medicine and wellness that might best fit in the context of digital health (diet, exercise, compliance, etc.)?

They all do.

6. There is much talk on the empowerment of the individual and the “democratization of data”.  From your perspective are patients becoming more engaged and involved in their care?

Patients are becoming more empowered in all areas of life, not just with their health care.  Having access to one’s clinical data can be useful, but even more empowering is access to tools and programs that enable people to use the experience of suffering as a catalyst and doorway for transforming their lives for the better.  That’s what our lifestyle program provides.

 7. Is digital health “sticking” in the medical community?  Or are advances being driven more by patients?

Electronic medical records are finally being embraced, in part due to financial incentives.  Also, telemedicine is about to take off, as it allows both health care professionals and patients to leverage their time and resources more efficiently and effectively.  But most doctors are not prescribing digital health devices for their patients.  Not yet.

 8. Do you personally use any devices?  Any success (or failure) stories?

I weigh myself every day, and I work out regularly using weight machines and a treadmill desk.  I feel overloaded by information much of the day, so I haven’t found devices such as FitBit, Nike Plus, and others to be useful.  These days, I find wisdom to be a more precious commodity than information.

 9. What are some of the exciting areas of digital health that you see on the horizon?

The capacity for intimacy using digital platforms is virtually unlimited, but, so far, we’ve only scratched the surface of what’s possible.  It’s a testimony to how primal our need is for love and intimacy that even the rather superficial intimacy of Facebook (or, before that, the chat rooms in AOL, or the lounges in Starbucks) created multi-billion-dollar businesses.

My wife, Anne, is a multidimensional genius who is developing ways of creating intimate and meaningful relationships using the interface of digital technologies and real-world healing environments.  She also designed our web site (www.ornish.com) and created and appears in the guided meditations there; Anne has a unique gift of making everyone and everything around her beautiful.

 10. Medicare is now covering Dr. Dean Ornish’s Program for Reversing Heart Disease as a branded program–a landmark event–and you recently formed a partnership with Healthways to train health care professionals, hospitals, and clinics nationwide.  Why now?

We’re creating a new paradigm of health care—Lifestyle Medicine—instead of sick care, based on lifestyle changes astreatment, not just as prevention.  Lifestyle changes often work better than drugs and surgery at a fraction of the cost—and the only side-effects are good ones.  Like an electric car or an iPhone, this is a disruptive innovation.  After 37 years of doing work in this area, this is the right idea at the right time.

The limitations of high-tech medicine are becoming clearer—e.g., angioplasty, stents, and bypass surgery don’t prolong life or prevent heart attacks in stable patient; only one out of 49 men treated for prostate cancer benefit from the treatment, and the other 48 often become impotent, incontinent or both; and drug treatments of type 2 diabetes don’t work nearly as well as lifestyle changes in preventing the horrible complications.

At the same time, the power of comprehensive lifestyle changes is becoming more well-documented.  In our studies, we proved, for the first time, that intensive lifestyle changes can reverse the progression of coronary heart disease and slow, stop, or reverse the progression of early-stage prostate cancer.  Also, we found that changing your lifestyle changes your genes—turning on hundreds of good genes that protect you while downregulating hundreds of genes that promote heart disease, cancer, and other chronic diseases.  Our most recent research found that these lifestyle changes may begin to reverse aging at a cellular level by lengthening our telomeres, the ends of our chromosomes that control how long we live.

Finally, Obamacare turns economic incentives on their ear, so it becomes economically sustainable for physicians to offer training in comprehensive lifestyle changes to their patients, especially now that CMS is providing Medicare reimbursement and insurance companies such as WellPoint are also doing so.  Ben Leedle, CEO of Healthways, is a visionary leader who has the experience, resources, and infrastructure for us to quickly scale our program to those who most need it.  Recently, we trained UCLA, The Cleveland Clinic, and the Beth Israel Medical Center in New York in our program, and many more are on the way.